ZBH - Zimmer Biomet Holdings Inc Stock Price, Fair Value and News

120.83USD-0.60 (-0.49%)Market Closed

Market Summary

USD120.83-0.60

Market Closed

-0.49%

ZBH Stock Price

View Fullscreen

ZBH RSI Chart

ZBH Valuation

Market Cap

24.9B

Price/Earnings (Trailing)

25.79

Price/Sales (Trailing)

3.34

EV/EBITDA

16.73

Price/Free Cashflow

20.67

ZBH Price/Sales (Trailing)

ZBH Profitability

EBT Margin

13.36%

Return on Equity

7.65%

Return on Assets

4.49%

Free Cashflow Yield

4.84%

ZBH Fundamentals

ZBH Revenue

Revenue (TTM)

7.5B

Rev. Growth (Yr)

3.18%

Rev. Growth (Qtr)

-2.62%

ZBH Earnings

Earnings (TTM)

963.9M

Earnings Growth (Yr)

-25.85%

Earnings Growth (Qtr)

-58.87%

Breaking Down ZBH Revenue

Last 7 days

1.1%

Last 30 days

-4.6%

Last 90 days

-1.8%

Trailing 12 Months

-11.2%

How does ZBH drawdown profile look like?

ZBH Financial Health

Current Ratio

1.66

Debt/Equity

0.38

Debt/Cashflow

0.31

ZBH Investor Care

Dividend Yield

0.79%

Dividend/Share (TTM)

0.96

Buy Backs (1Y)

1.36%

Diluted EPS (TTM)

4.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	7.5B	0	0	0
2023	7.1B	7.2B	7.3B	7.4B
2022	6.9B	6.9B	6.9B	6.9B
2021	6.8B	7.4B	7.1B	6.8B
2020	7.8B	7.0B	7.1B	7.0B
2019	7.9B	7.9B	7.9B	8.0B
2018	7.8B	7.9B	7.9B	7.9B
2017	7.8B	7.8B	7.7B	7.8B
2016	6.8B	7.5B	7.6B	7.7B
2015	4.6B	4.6B	5.3B	6.0B
2014	4.6B	4.7B	4.7B	4.7B
2013	4.5B	4.5B	4.6B	4.6B
2012	4.5B	4.5B	4.5B	4.5B
2011	4.3B	4.4B	4.4B	4.5B
2010	4.2B	4.2B	4.2B	4.2B
2009	4.1B	4.0B	4.0B	4.1B
2008	0	4.0B	4.0B	4.1B
2007	0	0	0	3.9B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Zimmer Biomet Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	winkler lori	acquired	-	-	772	svp and chro
Apr 01, 2024	winkler lori	sold (taxes)	-28,089	130	-215	svp and chro
Mar 07, 2024	yi sang	sold	-216,296	126	-1,705	group president, asia pacific
Mar 07, 2024	yi sang	acquired	156,059	91.53	1,705	group president, asia pacific
Mar 06, 2024	ellingson rachel	sold (taxes)	-55,989	125	-445	svp & chief strategy officer
Mar 06, 2024	upadhyay suketu	sold (taxes)	-241,449	125	-1,919	exec. vp, cfo
Mar 06, 2024	upadhyay suketu	acquired	-	-	4,561	exec. vp, cfo
Mar 06, 2024	phipps chad f	sold (taxes)	-103,802	125	-825	sr. vp/gen counsel/secretary
Mar 06, 2024	yi sang	acquired	-	-	2,365	group president, asia pacific
Mar 06, 2024	stellato paul a	acquired	-	-	609	vp, controller & cao

Which funds bought or sold ZBH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Ardent Capital Management, Inc.	unchanged	-	134,935	1,732,370	0.87%
May 07, 2024	OPPENHEIMER & CO INC	added	0.94	263,090	3,043,330	0.05%
May 07, 2024	WestEnd Advisors, LLC	unchanged	-	31.00	396	-%
May 07, 2024	CHILTON CAPITAL MANAGEMENT LLC	sold off	-100	-3,651	-	-%
May 07, 2024	ASSETMARK, INC	reduced	-32.69	-1,175,160	3,177,480	0.01%
May 07, 2024	MONTAG A & ASSOCIATES INC	unchanged	-	1,645	21,156	-%
May 07, 2024	Empowered Funds, LLC	added	201	688,054	991,696	0.01%
May 07, 2024	Smithfield Trust Co	unchanged	-	6,000	77,000	-%
May 07, 2024	Williams Jones Wealth Management, LLC.	reduced	-8.12	-1,431	395,676	-%
May 07, 2024	PANAGORA ASSET MANAGEMENT INC	reduced	-97.2	-65,331,600	2,048,860	0.01%

Are Funds Buying or Selling ZBH?

Are funds buying ZBH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ZBH

No. of Funds

Unveiling Zimmer Biomet Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	price t rowe associates inc /md/	4.5%	9,426,866	SC 13G
Feb 13, 2024	dodge & cox	5.5%	11,474,535	SC 13G
Feb 13, 2024	vanguard group inc	11.42%	23,858,865	SC 13G/A
Jan 25, 2024	blackrock inc.	9.0%	18,704,377	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	5.3%	11,200,109	SC 13G
Feb 09, 2023	vanguard group inc	11.46%	24,055,739	SC 13G/A
Jan 30, 2023	blackrock inc.	10.4%	21,803,709	SC 13G/A
Jan 24, 2023	blackrock inc.	10.4%	21,803,709	SC 13G/A
Nov 07, 2022	jpmorgan chase & co	2.4%	5,091,869	SC 13G/A
Apr 08, 2022	vanguard group inc	11.04%	23,102,761	SC 13G/A

Recent SEC filings of Zimmer Biomet Holdings Inc

View All Filings

Date Filed	Form Type	Document
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 03, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading
Apr 02, 2024	4	Insider Trading

Peers (Alternatives to Zimmer Biomet Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	182.6B	40.3B	-5.05%	-4.82%	32.45	4.53	-2.84%	-3.08%
BDX	67.4B	19.7B	-3.45%	-6.52%	50.6	3.42	4.82%	-17.56%
ALGN	20.6B	3.9B	-14.54%	-9.65%	44.54	5.26	5.72%	46.72%
BAX	18.2B	14.9B	-15.38%	-17.01%	6.88	1.22	2.98%	207.68%
MID-CAP
ATR	10.0B	3.5B	7.32%	25.05%	31.94	2.82	6.16%	35.06%
HSIC	9.3B	12.5B	0.39%	-2.78%	24.01	0.75	-0.61%	-18.83%
BIO	7.8B	2.7B	-17.82%	-26.90%	-12.29	2.93	-4.68%	82.43%
XRAY	5.8B	3.9B	-13.74%	-32.04%	-61.76	1.47	0.23%	91.03%
AXNX	3.4B	387.1M	-0.59%	20.47%	-215.56	8.87	30.82%	65.57%
PDCO	2.3B	6.6B	-1.26%	-0.69%	11.98	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-6.92%	-14.34%	-1.85	0.4	7.94%	-1661.78%
ANIK	423.5M	166.7M	11.74%	12.93%	-5.12	2.54	6.67%	-456.34%
ANGO	236.7M	324.0M	-10.59%	-34.33%	-1.23	0.73	-3.19%	-337.41%
APYX	45.4M	52.3M	-10.27%	-60.90%	-2.43	0.87	17.61%	19.28%
AEMD	3.3M	3.7M	-25.00%	250.00%	-0.27	0.88	5.77%	8.23%

Zimmer Biomet Holdings Inc News

Latest updates

Zimmer Biomet Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-2.6%	1,889	1,940	1,754	1,870	1,831	1,825	1,670	1,782	1,663	1,777	1,685	1,763	1,601	2,085	1,929	1,226	1,784	2,126	1,892	1,989	1,976
Costs and Expenses	2.4%	1,623	1,586	1,487	1,540	1,504	1,853	1,425	1,501	1,465	1,643	1,442	1,539	1,343	777	1,630	1,398	2,240	793	1,647	1,784	1,625
S&GA Expenses	1.9%	736	722	675	726	716	727	655	695	685	805	684	697	657	429	790	665	829	349	826	839	796
EBITDA Margin	-4.5%	0.23*	0.25*	0.20*	0.20*	0.19*	0.17*	0.17*	0.17*	0.16*	0.18*	0.22*	0.22*	-	-	-	-	-	-	-	-	-
Interest Expenses	-0.8%	-50.70	-50.30	-51.10	-51.60	-48.20	-42.60	-42.30	-38.80	-41.10	-48.80	-52.60	-54.70	-52.30	-53.20	-54.00	-54.00	-50.90	-52.50	-56.80	-59.70	-58.00
Income Taxes	131.3%	42.00	-135	56.00	67.00	54.00	55.00	-16.60	46.00	28.00	-29.20	28.00	33.00	21.00	-97.20	10.00	-13.70	5.00	-44.50	-247	8.00	46.00
Earnings Before Taxes	-24.4%	215	285	219	277	287	-74.80	178	200	101	-83.90	191	178	214	365	256	-221	-503	264	185	140	292
EBT Margin	-7.4%	0.13*	0.14*	0.10*	0.09*	0.08*	0.06*	0.06*	0.06*	0.06*	0.07*	0.13*	0.14*	-	-	-	-	-	-	-	-	-
Net Income	-58.9%	172	419	163	210	233	-130	194	154	14.00	-84.00	146	142	198	334	243	-206	-508	321	431	134	246
Net Income Margin	-6.6%	0.13*	0.14*	0.07*	0.07*	0.06*	0.03*	0.04*	0.03*	0.03*	0.06*	0.11*	0.12*	-	-	-	-	-	-	-	-	-
Free Cashflow	-67.1%	173	526	253	251	261	181	404	305	279	288	380	394	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.2%	21,452	21,497	21,217	21,294	21,244	21,066	21,333	21,453	21,618	23,456	24,009	24,223	24,027	24,418	24,026	23,648	25,513	24,639	24,315	24,206	24,289
Current Assets	0.5%	4,632	4,610	4,372	4,388	4,412	4,427	4,534	4,463	4,517	4,885	5,312	5,357	5,000	5,083	5,153	4,707	6,371	4,724	4,402	4,391	4,499
Cash Equivalents	-5.5%	393	416	292	320	330	376	545	386	436	378	920	1,042	724	775	967	713	2,434	618	513	403	587
Inventory	0.1%	2,388	2,385	2,323	2,276	2,241	2,147	2,129	2,123	2,132	2,148	2,517	2,533	2,512	2,174	2,492	2,497	2,463	2,385	2,362	2,345	2,310
Net PPE	1.5%	2,091	2,060	2,032	1,975	1,906	1,873	1,802	1,797	1,826	1,837	2,008	2,005	2,022	1,864	2,043	2,057	2,066	2,077	2,055	2,036	2,014
Goodwill	-0.3%	8,792	8,819	8,710	8,744	8,735	8,580	8,799	8,869	8,896	8,919	9,212	9,248	9,233	8,983	9,039	8,982	8,951	9,197	9,545	9,594	9,570
Liabilities	-1.8%	8,846	9,009	8,699	8,916	9,086	9,039	9,082	9,328	9,596	10,790	11,294	11,640	11,577	12,218	12,147	12,004	13,630	12,246	12,230	12,544	12,750
Current Liabilities	-2.1%	2,797	2,857	2,072	2,234	2,336	2,358	2,296	2,464	2,674	3,468	2,939	2,929	2,089	2,557	2,266	2,161	3,780	3,442	3,774	3,678	2,255
Long Term Debt	-0.9%	4,826	4,868	5,127	5,189	5,205	5,152	5,055	5,172	5,286	5,464	6,458	6,803	7,539	7,627	7,840	7,759	7,724	6,721	6,346	6,719	8,311
LT Debt, Current	7.8%	970	900	355	520	585	544	659	852	1,015	1,605	1,046	1,050	300	500	450	450	1,950	1,500	2,000	2,000	500
LT Debt, Non Current	-100.0%	-	4,868	5,127	5,189	5,205	5,152	5,055	5,172	5,286	5,464	6,458	6,803	7,539	7,627	7,840	7,759	7,724	6,721	6,346	6,719	8,311
Shareholder's Equity	1.0%	12,606	12,481	12,511	12,379	12,158	12,020	12,251	12,125	12,021	12,666	12,714	12,583	12,450	12,199	11,878	11,644	11,883	12,393	12,086	11,662	11,539
Retained Earnings	1.2%	10,509	10,385	10,015	9,902	9,742	9,559	9,740	9,607	9,503	10,292	10,426	10,331	10,238	10,087	9,803	9,610	9,866	10,427	10,155	9,773	9,688
Additional Paid-In Capital	1.0%	9,946	9,846	9,801	9,766	9,692	9,504	9,464	9,419	9,386	9,315	9,295	9,249	9,199	9,122	9,073	9,014	8,984	8,920	8,867	8,777	8,748
Shares Outstanding	-1.7%	205	209	209	209	209	210	210	209	209	209	209	209	-	-	-	-	-	-	-	-	-
Minority Interest	5.2%	8.00	8.00	7.00	7.00	7.00	7.00	6.00	6.00	6.00	6.00	6.00	5.00	5.00	5.00	6.00	3.00	4.00	5.00	4.00	3.00	5.00
Float	-	-	-	-	30,367	-	-	-	22,003	-	-	-	33,533,707,317	-	-	-	24,675,479,718	-	-	-	24,106	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-61.3%	228	588	338	348	308	244	451	346	316	338	424	419	224	296	381	-52.80	451	227	578	301	284
Share Based Compensation	14.6%	29.00	25.00	16.00	34.00	25.00	27.00	27.00	28.00	23.00	15.00	19.00	22.00	20.00	12.00	24.00	22.00	17.00	16.00	22.00	20.00	20.00
Cashflow From Investing	11.7%	-195	-220	-165	-243	-149	-112	-85.20	-243	-81.10	-124	-112	-98.90	-108	-266	-91.40	-85.30	-121	-53.40	-163	-322	-105
Cashflow From Financing	80.1%	-50.10	-251	-196	-109	-206	-313	-193	-146	-122	-655	-426	-28.30	-195	-284	-42.60	-1,585	1,493	-180	-298	-163	-135
Dividend Payments	-1.6%	49.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	49.00	49.00	49.00	49.00
Buy Backs	-72.3%	114	410	-	14.00	268	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ZBH Income Statement

2024-03-31

Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net Sales	$ 1,889.2	$ 1,831.0
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 512.3	$ 500.8
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 142.1	$ 133.4
Research and development	107.9	110.4
Selling, general and administrative	736.2	715.9
Restructuring and other cost reduction initiatives	124.4	41.8
Acquisition, integration, divestiture and related	0.4	1.3
Operating expenses	1,623.3	1,503.7
Operating Profit	265.9	327.3
Other (expense) income, net	(0.1)	7.7
Interest expense, net	(50.7)	(48.2)
Earnings before income taxes	215.1	286.8
Provision for income taxes	42.3	54.1
Net Earnings	172.8	232.8
Less: Net earnings attributable to noncontrolling interest	0.4	0.2
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 172.4	$ 232.5
Earnings Per Common Share
Basic	$ 0.84	$ 1.11
Diluted	$ 0.84	$ 1.11
Weighted Average Common Shares Outstanding
Basic	205.2	209.4
Diluted	206.2	210.4

ZBH Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 393.0	$ 415.8
Accounts receivable, less allowance for credit losses	1,446.4	1,442.4
Inventories	2,388.2	2,385.2
Prepaid expenses and other current assets	403.8	366.1
Total Current Assets	4,631.5	4,609.5
Property, plant and equipment, net	2,090.9	2,060.4
Goodwill	8,791.5	8,818.5
Intangible assets, net	4,734.1	4,856.4
Other assets	1,204.4	1,152.1
Total Assets	21,452.4	21,496.9
Current Liabilities:
Accounts payable	370.3	410.6
Income taxes payable	70.3	61.2
Other current liabilities	1,386.3	1,485.7
Current portion of long-term debt	970.0	900.0
Total Current Liabilities	2,797.0	2,857.4
Deferred income taxes, net	370.4	357.6
Long-term income tax payable	275.8	273.7
Other long-term liabilities	577.0	652.1
Long-term debt	4,826.2	4,867.9
Total Liabilities	8,846.4	9,008.7
Commitments and Contingencies (Note 15)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 317.2 million shares as of March 31, 2024 (316.2 million as of December 31, 2023) issued	3.2	3.2
Paid-in capital	9,945.9	9,846.1
Retained earnings	10,509.0	10,384.5
Accumulated other comprehensive loss	(211.2)	(191.0)
Treasury stock, 111.5 million shares as of March 31, 2024 (110.6 million as of December 31, 2023)	(7,648.9)	(7,562.3)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,598.0	12,480.5
Noncontrolling interest	8.1	7.7
Total Stockholders' Equity	12,606.0	12,488.1
Total Liabilities and Stockholders' Equity	$ 21,452.4	$ 21,496.9

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

CEO	Mr. Ivan Tornos
WEBSITE	zimmerbiomet.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	18000

Zimmer Biomet Holdings Inc Frequently Asked Questions

What is the ticker symbol for Zimmer Biomet Holdings Inc? What does ZBH stand for in stocks?

ZBH is the stock ticker symbol of Zimmer Biomet Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Zimmer Biomet Holdings Inc (ZBH)?

As of Wed May 08 2024, market cap of Zimmer Biomet Holdings Inc is 24.86 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ZBH stock?

You can check ZBH's fair value in chart for subscribers.

What is the fair value of ZBH stock?

You can check ZBH's fair value in chart for subscribers. The fair value of Zimmer Biomet Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Zimmer Biomet Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ZBH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Zimmer Biomet Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether ZBH is over valued or under valued. Whether Zimmer Biomet Holdings Inc is cheap or expensive depends on the assumptions which impact Zimmer Biomet Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ZBH.

What is Zimmer Biomet Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, ZBH's PE ratio (Price to Earnings) is 25.79 and Price to Sales (PS) ratio is 3.34. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ZBH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Zimmer Biomet Holdings Inc's stock?

In the past 10 years, Zimmer Biomet Holdings Inc has provided 0.028 (multiply by 100 for percentage) rate of return.